bioMérieux S.A. (BMXMF)
USD 130.17
(6.22%)
USD 130.17
(6.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 700.8 Million EUR | -12.15% |
| 2022 | 832.6 Million EUR | -8.83% |
| 2021 | 1 Billion EUR | 27.82% |
| 2020 | 808.9 Million EUR | 39.66% |
| 2019 | 558.9 Million EUR | 10.89% |
| 2018 | 517.3 Million EUR | 9.43% |
| 2017 | 477.3 Million EUR | 8.48% |
| 2016 | 440 Million EUR | 16.71% |
| 2015 | 314.3 Million EUR | 11.64% |
| 2014 | 307.5 Million EUR | -5.54% |
| 2013 | 357.5 Million EUR | 7.97% |
| 2012 | 331.1 Million EUR | -3.5% |
| 2011 | 327.1 Million EUR | 3.06% |
| 2010 | 332.9 Million EUR | 26.1% |
| 2009 | 264 Million EUR | 2.33% |
| 2008 | 256.7 Million EUR | -1.6% |
| 2007 | 249.8 Million EUR | 26.12% |
| 2006 | 207.9 Million EUR | -1.14% |
| 2005 | 210.7 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 399.8 Million EUR | -16.34% |
| 2023 Q4 | 421.5 Million EUR | 12.82% |
| 2023 FY | - EUR | -12.15% |
| 2023 Q2 | 373.6 Million EUR | -12.42% |
| 2022 FY | - EUR | -8.83% |
| 2022 Q2 | 390.8 Million EUR | -27.14% |
| 2022 Q4 | 426.6 Million EUR | 9.16% |
| 2021 Q4 | 536.4 Million EUR | 18.91% |
| 2021 FY | - EUR | 27.82% |
| 2021 Q2 | 451.1 Million EUR | -0.68% |
| 2020 Q4 | 454.2 Million EUR | 39.62% |
| 2020 FY | - EUR | 39.66% |
| 2020 Q2 | 325.3 Million EUR | 19.68% |
| 2019 Q2 | 266.5 Million EUR | 2.19% |
| 2019 Q4 | 271.8 Million EUR | 1.99% |
| 2019 FY | - EUR | 10.89% |
| 2018 Q2 | 258.39 Million EUR | 15.87% |
| 2018 FY | - EUR | 9.43% |
| 2018 Q4 | 260.8 Million EUR | 0.93% |
| 2017 Q4 | 223 Million EUR | -11.51% |
| 2017 FY | - EUR | 8.48% |
| 2017 Q2 | 252 Million EUR | 11.7% |
| 2016 Q4 | 225.6 Million EUR | 5.87% |
| 2016 FY | - EUR | 16.71% |
| 2016 Q2 | 213.1 Million EUR | 3.9% |
| 2015 FY | - EUR | 11.64% |
| 2015 Q4 | 205.1 Million EUR | 14.71% |
| 2015 Q2 | 178.8 Million EUR | -9.05% |
| 2014 Q2 | 136.2 Million EUR | -22.39% |
| 2014 FY | - EUR | -5.54% |
| 2014 Q4 | 196.6 Million EUR | 44.35% |
| 2013 Q4 | 175.5 Million EUR | 3.91% |
| 2013 FY | - EUR | 7.97% |
| 2013 Q2 | 168.9 Million EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | - EUR | -3.5% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 FY | - EUR | 3.06% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | - EUR | 26.1% |
| 2010 Q4 | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 FY | - EUR | 2.33% |
| 2008 FY | - EUR | -1.6% |
| 2007 FY | - EUR | 26.12% |
| 2006 FY | - EUR | -1.14% |
| 2005 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 60357.954% |
| Arrayit Corporation | -3.07 Million USD | 22871.767% |
| Atlantic International Corp. | -5.38 Million USD | 13102.917% |
| Biocept, Inc. | -30.24 Million USD | 2417.384% |
| Bioqual, Inc. | 3.03 Million USD | -23011.627% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 92630.12% |
| DermTech, Inc. | -97.89 Million USD | 815.884% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 75.952% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 3562.03% |
| iMD Companies, Inc. | -154.65 Thousand USD | 453225.909% |
| IDenta Corp. | 71.58 Thousand USD | -978848.692% |
| Interpace Biosciences, Inc. | 3.83 Million USD | -18164.269% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -1811220.755% |
| InVitro International | 6680.00 USD | -10490917.964% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 12991.832% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 5775606.84% |
| Medical Imaging Corp. | -896.74 Thousand USD | 78249.568% |
| NovelStem International Corp. | -3.78 Million USD | 18611.284% |
| Optigenex Inc. | -1.18 Million USD | 59153.327% |
| PharmChem, Inc. | 1.05 Million USD | -66401.552% |
| Proteome Sciences plc | -1.13 Million USD | 61735.884% |
| Response Genetics, Inc | -19.66 Million USD | 3663.511% |
| Rennova Health, Inc. | -234.81 Thousand USD | 298547.714% |
| RushNet, Inc. | -614.85 Thousand USD | 114078.649% |
| ScreenPro Security Inc. | -3.43 Million USD | 20502.406% |
| Stella Diagnostics Inc. | -5.7 Million USD | 12378.731% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 6923.666% |
| Todos Medical Ltd. | -9.39 Million USD | 7560.081% |